197 related articles for article (PubMed ID: 18427761)
1. [A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)].
Schmidt A; Schwella N; Helmchen U; von Renteln D; Caca K
Internist (Berl); 2008 Aug; 49(8):989-90, 992-4. PubMed ID: 18427761
[TBL] [Abstract][Full Text] [Related]
2. [Thrombotic microangiopathy under an effective treatment with gemcitabine].
Finkenwirth P; Schick D; Horger MS; Fend F; Lauer UM; Gregor M; Bitzer M
Z Gastroenterol; 2009 Mar; 47(3):288-91. PubMed ID: 19280543
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Held-Warmkessel J
Oncol Nurs Forum; 2014 Sep; 41(5):551-3. PubMed ID: 25158661
[TBL] [Abstract][Full Text] [Related]
4. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
Saif MW; McGee PJ
JOP; 2005 Jul; 6(4):369-74. PubMed ID: 16006690
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports
.
López Rubio ME; Rodado Martínez R; Illescas ML; Mateo Bosch E; Martinez Díaz M; de la Vara Inesta L; Cabezuelo B; Morales Albuja ME; Lucas Guillén E; Jimeno García L
Clin Nephrol; 2017 Feb; 87 (2017)(2):100-106. PubMed ID: 27879189
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine-associated thrombotic microangiopathy.
Humphreys BD; Sharman JP; Henderson JM; Clark JW; Marks PW; Rennke HG; Zhu AX; Magee CC
Cancer; 2004 Jun; 100(12):2664-70. PubMed ID: 15197810
[TBL] [Abstract][Full Text] [Related]
7. [Hemolytic-uremic syndrome associated with gemcitabine use: report of one case].
Vega J; Parodi C; Méndez GP; Goecke H
Rev Med Chil; 2013 Jun; 141(6):797-802. PubMed ID: 24121585
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma.
Kalra N; Kad R; Osama S
Int J Clin Oncol; 2007 Oct; 12(5):385-7. PubMed ID: 17929123
[TBL] [Abstract][Full Text] [Related]
9. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
[TBL] [Abstract][Full Text] [Related]
10. Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab.
Gourley BL; Mesa H; Gupta P
Cancer Chemother Pharmacol; 2010 Apr; 65(5):1001-4. PubMed ID: 20119714
[TBL] [Abstract][Full Text] [Related]
11. Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.
Nieto-Ríos JF; Zuluaga-Quintero M; Higuita LM; Rincón CI; Galvez-Cárdenas KM; Ocampo-Kohn C; Aristizabal-Alzate A; Florez-Vargas AA; Zuluaga-Valencia GA
J Bras Nefrol; 2016 Jun; 38(2):255-9. PubMed ID: 27438981
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine.
Vénat-Bouvet L; Ly K; Szelag JC; Martin J; Labourey JL; Genet D; Tubiana-Mathieu N
Anticancer Drugs; 2003 Nov; 14(10):829-32. PubMed ID: 14597878
[TBL] [Abstract][Full Text] [Related]
13. [Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature].
Desramé J; Duvic C; Bredin C; Béchade D; Artru P; Brézault C; Defuentes G; Poirier JM; Dourthe LM; Coutant G; Chaussade S; de Gramont A; Algayres JP
Rev Med Interne; 2005 Mar; 26(3):179-88. PubMed ID: 15777580
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
Flombaum CD; Mouradian JA; Casper ES; Erlandson RA; Benedetti F
Am J Kidney Dis; 1999 Mar; 33(3):555-62. PubMed ID: 10070921
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic microangiopathy associated with gemcitabine: rare but real.
Saif MW; Xyla V; Makrilia N; Bliziotis I; Syrigos K
Expert Opin Drug Saf; 2009 May; 8(3):257-60. PubMed ID: 19505260
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin.
Reese JA; Bougie DW; Curtis BR; Terrell DR; Vesely SK; Aster RH; George JN
Am J Hematol; 2015 May; 90(5):406-10. PubMed ID: 25639727
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy.
Lhotta K; Kühr T; Rumpelt HJ; Wöll E; Thaler J; König P
Am J Nephrol; 1999; 19(5):590-3. PubMed ID: 10575189
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine-associated thrombotic thrombocytopenic purpura.
Zupancic M; Shah PC; Shah-Khan F
Lancet Oncol; 2007 Jul; 8(7):634-41. PubMed ID: 17613425
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy in a sirolimus-treated renal transplant patient receiving gemcitabine for lung cancer.
Courtellemont C; Guitard J; Mehrenberger M; Pontier S; Ribes D; Kamar N; Esposito L; Modesto A; Rostaing L
Clin Nephrol; 2007 Feb; 67(2):114-8. PubMed ID: 17338432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
